Pierre Fabre Dermo-cosmetics confirms the strength of the market and reinforces its commitment to pharmacies

For the past two years, Pierre Fabre Dermo-cosmetics has outperformed the market, confirming the relevance of its strategy and the solidity of its business model. The Avène brand, for example, has consolidated its leadership position, and Ducray, which has been in decline for several years, is regaining market share for the second year running. 

This dynamic performance comes against a demanding backdrop of increasing competition, strong pressure on shelf space and growing economic challenges for local pharmacies.

To keep pace with this changing market, Pierre Fabre Dermo-cosmétique relies on its dual medical and dermo-cosmetic expertise, a genuine differentiating factor. The Group is continuing to invest in research and development in order to offer ever more innovative solutions tailored to patients' needs.

Alongside this, significant industrial and logistical investments are reinforcing security of supply, improving responsiveness and reducing the environmental footprint, with production overwhelmingly carried out in France.

As a long-standing partner of pharmacies, Pierre Fabre Dermo-cosmétique supports pharmacists in the evolution of their role within the care pathway. With the help of support systems, educational content and advisory solutions, the Group is helping to make dermo-cosmetics a lever for value creation while meeting public health challenges.

At a time when access to dermatological care is under pressure, these initiatives are helping to provide patients with rapid, appropriate responses, including in the most vulnerable areas.

.